predicTx Health raises $1.6M for precision oncology AI | PredicTx Health posted on the topic | LinkedIn
Summary
predicTx Health raised $1.6 million in pre-seed funding to advance its precision oncology platform. The company uses deep learning on standard CT scans to produce body composition analyses for more personalized chemotherapy dosing. The round included the University of Melbourne Genesis Pre-Seed Fund, angel investors, and non-dilutive support from Australian public programs. This funding should help predicTx Health continue building and validating its AI-driven clinical software for cancer treatment.
Funding
Amount
$1.6M
Total raised
Date
October 8, 2025
Announcement date
Investors
-
Lead investors
Company
-
Funded company
Classifications
industries
No industries detected
applications
No applications detected
AskAI Classifications
Labels
No AI classifications detected